InMed Pharmaceuticals Inc. (INM) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

InMed Pharmaceuticals Inc...

NASDAQ: INM · Real-Time Price · USD
2.28
-0.01 (-0.44%)
At close: Oct 06, 2025, 11:03 AM

InMed Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
381.25K -2.12M -2.57M -1.68M -1.94M -1.72M -1.48M -2.54M -338.39K -2M -2.1M -3.51M -7.87M -3.48M -4.28M -2.97M -3.26M -3.1M -2.24M -1.6M
Depreciation & Amortization
-11.08K 129.58K 128.99K 144.98K 151.86K 150.38K 152.61K 149.36K 150.97K 149.16K 147.36K 148.51K -152.02K -151.02K 175.88K 28.53K 28.65K 27.42K 36.82K 27.98K
Stock-Based Compensation
-4.99K 40.45K 23.14K 28.96K 38.95K 55.3K 18.26K 25.19K 40.48K 50.36K 70.64K 116.68K 176.89K 195.09K 214.78K 111.14K 220.85K 207.3K 96.63K 85.41K
Other Working Capital
383.68K 81.28K -232.75K -420.03K 46.43K -36.46K 28.66K -16.17K 779.13K -53.12K -1.03M 15.7K -176.52K -1.66M 480.18K 171.21K 952.34K -1.83M 272.9K 115.03K
Other Non-Cash Items
12.02K 25.98K 14.7K 4.75K -321.77K 719.47K -481 -538 -7.89M -3 125.06K -120 5M 190.98K -133.59K 8.47K -8.21K 2.08K 375.87K 4.48K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 169.43K 94.95K 7.64M n/a n/a n/a 108.37K 69.8K 11.13K 1.26K 653.00 -549 -242.63K 140.00
Change in Working Capital
-91.25K 265.42K -94K -327.64K 1.04M -423.34K -709.77K 93.65K -263.48K 141.8K -955.06K 410.02K -1.25M -2.1M 480.81K 168.29K 1.01M -1.75M 175.73K 109.48K
Operating Cash Flow
285.95K -1.66M -2.5M -1.83M -1.03M -1.96M -1.85M -2.17M -657.93K -1.66M -2.71M -2.26M -3.99M -5.27M -3.53M -2.65M -2.01M -4.61M -1.8M -1.37M
Capital Expenditures
n/a n/a n/a n/a 9.29K -71.46 -9.22K n/a -33.61K -128.2K n/a n/a 78.68 -3.3K n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a -118.45K 490.38K -490.38K n/a 90.78K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
71.06K -16.04K -2.68K -21.32K 431.00 -21.35K 163.66 -21.32K -42.16K n/a n/a n/a -421.36K n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
-71.06K 16.04K 2.68K 21.32K -431 21.35K -163.66 21.32K 42.16K n/a n/a n/a -90.97K -581.43 n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -8.93K n/a -71.33 n/a 118.45K -490.38K -9.62K n/a -297.88K -0.00 306.01K -250K -1.73K n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a 362.46 -71.46 -9.29K n/a -33.61K -128.2K -500K n/a -719.34K -3.89K 306.01K -250K -1.73K n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 395.69K -29.31K n/a n/a n/a n/a n/a -21.64K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.95M -15.1K -57.59K -191.82K 175.00 n/a n/a n/a -654 -22.39K 571.26K -571.26K -490.54K n/a -836.32K -1.12M -103.12K -417.63K -1.05M -43.36K
Financial Cash Flow
4.91M 2.92M 338.29K 838.24K 176.00 34.79K 4.65M n/a -654 -63.7K 5.32M 5.43M 4.99M -92.93K -836.14K 10.88M -83.18K 4.04M 6.96M -64.65K
Net Cash Flow
3.45M 1.26M -2.16M -988.58K -1.03M -1.93M 2.8M -2.17M -691.54K -1.85M 2.1M 3.17M 278.55K -5.38M -4.06M 7.98M -2.09M -566.74K 5.52M -1.31M
Free Cash Flow
285.95K -1.66M -2.5M -1.83M -1.03M -1.96M -1.86M -2.17M -691.54K -1.78M -2.71M -2.26M -3.99M -5.28M -3.53M -2.65M -2.01M -4.61M -1.8M -1.37M